XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 235,000 $ 1,891,000
Trade accounts receivable, net 829,000 821,000
Other receivables 55,000 160,000
Inventory, net 1,500,000 1,214,000
Prepaid expenses and other current assets 104,000 67,000
Total current assets 2,723,000 4,153,000
Property, plant and equipment, net of depreciation 333,000 409,000
Intangible assets, net of amortization 178,000 241,000
Other non-current assets 84,000 7,000
Total assets 3,318,000 4,810,000
Current liabilities:    
Line of credit 609,000
Accounts payable 1,200,000 1,670,000
Disputed co-manufacturer accounts payable (Note 6) 499,000 499,000
Accrued expenses 142,000 85,000
Accrued payroll and employee related expenses 67,000 53,000
Financing agreements - current 99,000
Total current liabilities 2,616,000 2,307,000
Financing agreements 124,000
Total liabilities 2,740,000 2,307,000
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.000001 par value, 400,000 shares authorized, none issued or outstanding
Common stock, $0.000001 par value; 23,000,000 shares authorized; 14,746,172 and 14,420,105 shares issued and outstanding at December 31, 2024 and 2023, respectively
Additional paid in capital 64,199,000 63,299,000
Accumulated deficit (63,621,000) (60,796,000)
Total stockholders’ equity 578,000 2,503,000
Total liabilities and stockholders’ equity $ 3,318,000 $ 4,810,000